Ufp Technologies (UFPT) Net Shares Issued and Repurchased (2012 - 2025)
Ufp Technologies' (UFPT) quarterly Net Shares Issued and Repurchased came in at $1396.0 in Q1 2025, up 965.65% on a YoY basis from $131.0 in Q1 2024, and down 99.66% quarter-over-quarter from $407980.0 in Q4 2024.
Powered by 
Analysis
Ufp Technologies (UFPT) Net Shares Issued and Repurchased (2012 - 2025) Analysis & Trends
Ufp Technologies (UFPT) has reported Net Shares Issued and Repurchased for 14 consecutive years, with $1396.0 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Net Shares Issued and Repurchased rose 965.65% year-over-year to $1396.0; the trailing twelve-month figure through Mar 2025 stood at $1396.0 (up 965.65% YoY), and the FY2024 full-year result was $407980.0, up 0.73% from the prior year.
- Net Shares Issued and Repurchased eased to $1396.0 in Q1 2025 per UFPT's latest filing, from $407980.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $407980.0 in Q4 2024 and bottomed at $21.0 in Q1 2022.
- Historically, Net Shares Issued and Repurchased has averaged $154213.9 across 5 years, with a median of $9325.5 in 2021.
- The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased jumped 37685.71% in 2023, then sank 98.35% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $10716.0 in 2021, then jumped by 3637.5% to $400510.0 in 2022, then climbed by 1.13% to $405022.0 in 2023, then advanced by 0.73% to $407980.0 in 2024, then tumbled by 99.66% to $1396.0 in 2025.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1396.0, $407980.0, and $131.0 for Q1 2025, Q4 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1,396.00 |
| Dec 31, 2024 | 407,980.00 |
| Mar 31, 2024 | 131.00 |
| Dec 31, 2023 | 405,022.00 |
| Mar 31, 2023 | 7,935.00 |
| Dec 31, 2022 | 400,510.00 |
| Mar 31, 2022 | 21.00 |
| Dec 31, 2021 | 10,716.00 |
| Dec 31, 2020 | 14,892.00 |
| Dec 31, 2019 | 365,026.00 |
| Dec 31, 2018 | 348,490.00 |
| Dec 31, 2017 | 338,146.00 |
| Mar 31, 2017 | 3,750.00 |
| Dec 31, 2016 | 17,184.00 |
| Dec 31, 2015 | 325,810.00 |
| Dec 31, 2014 | 289,782.00 |
| Mar 31, 2014 | 577.00 |
| Dec 31, 2013 | 97,362.00 |
| Mar 31, 2013 | 60,000.00 |
| Dec 31, 2012 | 11,250.00 |